Literature DB >> 22571981

Biomarkers of basic activities of daily living in Alzheimer's disease.

James R Hall1, Leigh A Johnson, Robert C Barber, Hoa T Vo, A Scott Winter, Sid E O'Bryant.   

Abstract

Functional impairment is common in Alzheimer's disease (AD) and related to increased caregiver burden and institutionalization. There is a dearth of research investigating the relationship between specific biomarkers and basic activities of daily living (BADLs) such as toileting, feeding, dressing, grooming, bathing, and ambulating. The present study examined the relationship between serum based biomarkers and specific ADLs in a sample of AD patients. Data were collected from 196 participants enrolled in the Texas Alzheimer's Research and Care Consortium Project and diagnosed with AD. BADLs were measured using the Lawton-Brody Physical Self-Maintenance Scale. A panel of 22 biomarkers previously found to be related to AD pathology was used for the analysis. Stepwise regression modeling was used to assess the link between the biomarkers and BADLs. Results were also examined by gender. Nine of the 22 biomarkers were significantly related to BADLs. When stratified by gender, the biomarkers accounted for 32% of the variance in the males and 27% in females. The pattern of significant biomarkers differed by gender with IL 7 and Tenascin C significantly related to BADLs for females and IL 15 significantly related to BADLs for males. The results of this study indicated that a small number of serum based biomarkers are related to BADLs, and these biomarkers differed by gender.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22571981      PMCID: PMC3644945          DOI: 10.3233/JAD-2012-111481

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  36 in total

1.  Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients.

Authors:  Xin Cheng; Libang Yang; Ping He; Rena Li; Yong Shen
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Longitudinal change of biomarkers in cognitive decline.

Authors:  Raymond Y Lo; Alan E Hubbard; Leslie M Shaw; John Q Trojanowski; Ronald C Petersen; Paul S Aisen; Michael W Weiner; William J Jagust
Journal:  Arch Neurol       Date:  2011-06-13

3.  Dependence and caregiver burden in Alzheimer's disease and mild cognitive impairment.

Authors:  Damien Gallagher; Aine Ni Mhaolain; Lisa Crosby; Deirdre Ryan; Loretto Lacey; Robert F Coen; Cathal Walsh; Davis Coakley; J Bernard Walsh; Conal Cunningham; Brian A Lawlor
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-01-13       Impact factor: 2.035

4.  A serum protein-based algorithm for the detection of Alzheimer disease.

Authors:  Sid E O'Bryant; Guanghua Xiao; Robert Barber; Joan Reisch; Rachelle Doody; Thomas Fairchild; Perrie Adams; Steven Waring; Ramon Diaz-Arrastia
Journal:  Arch Neurol       Date:  2010-09

Review 5.  Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.

Authors:  William T Hu; Alice Chen-Plotkin; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Leo McCluskey; Lauren Elman; Jason Karlawish; Howard I Hurtig; Andrew Siderowf; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2010-07-22       Impact factor: 17.088

6.  Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy.

Authors:  Yu Wang; Aneeka M Hancock; Joshua Bradner; Kathryn A Chung; Joseph F Quinn; Elaine R Peskind; Douglas Galasko; Joseph Jankovic; Cyrus P Zabetian; Hojoong M Kim; James B Leverenz; Thomas J Montine; Carmen Ginghina; Karen L Edwards; Katherine W Snapinn; David S Goldstein; Min Shi; Jing Zhang
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

7.  Is there a relationship between high C-reactive protein (CRP) levels and dementia?

Authors:  A Mancinella; M Mancinella; G Carpinteri; A Bellomo; C Fossati; V Gianturco; A Iori; E Ettorre; G Troisi; V Marigliano
Journal:  Arch Gerontol Geriatr       Date:  2009       Impact factor: 3.250

8.  Neuropathologic correlates of activities of daily living in Alzheimer disease.

Authors:  Gad A Marshall; Lynn A Fairbanks; Sibel Tekin; Harry V Vinters; Jeffrey L Cummings
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

9.  Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.

Authors:  Joseph J Locascio; Hiroaki Fukumoto; Liang Yap; Teodoro Bottiglieri; John H Growdon; Bradley T Hyman; Michael C Irizarry
Journal:  Arch Neurol       Date:  2008-06

10.  Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells.

Authors:  Diego Gómez-Nicola; Beatriz Valle-Argos; Noemí Pallas-Bazarra; Manuel Nieto-Sampedro
Journal:  Mol Biol Cell       Date:  2011-04-20       Impact factor: 4.138

View more
  7 in total

1.  Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer's Disease.

Authors:  Grace E Weber; Maria Khrestian; Elizabeth D Tuason; Yvonne Shao; Jagan Pillai; Stephen Rao; Hao Feng; Yadi Zhou; Feixiong Cheng; Tara M DeSilva; Shaun Stauffer; James B Leverenz; Lynn M Bekris
Journal:  J Immunol       Date:  2022-05-06       Impact factor: 5.426

2.  Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease.

Authors:  James R Hall; April R Wiechmann; Leigh A Johnson; Melissa Edwards; Robert C Barber; A Scott Winter; Meharvan Singh; Sid E O'Bryant
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.

Authors:  Alcibiades E Villarreal; Sid E O'Bryant; Melissa Edwards; Shantal Grajales; Gabrielle B Britton
Journal:  Neurodegener Dis Manag       Date:  2016-05-27

4.  Serum interleukin (IL)-15 as a biomarker of Alzheimer's disease.

Authors:  Ram J Bishnoi; Raymond F Palmer; Donald R Royall
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

Review 5.  The Role of Tenascin-C in Tissue Injury and Repair After Stroke.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

Review 6.  Astrocyte-secreted matricellular proteins in CNS remodelling during development and disease.

Authors:  Emma V Jones; David S Bouvier
Journal:  Neural Plast       Date:  2014-01-16       Impact factor: 3.599

7.  Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study.

Authors:  Andreas Pikwer; Markus Castegren; Sijal Namdar; Kaj Blennow; Henrik Zetterberg; Niklas Mattsson
Journal:  J Neuroinflammation       Date:  2017-09-29       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.